CV Risk Score Multipliers Suggested for Rheumatic Diseases CV Risk Score Multipliers Suggested for Rheumatic Diseases
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other rheumatic disease.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 30, 2022 Category: Cardiology Tags: Rheumatology News Source Type: news
Gender and Age and Adverse CV Outcomes in Systemic Sclerosis Gender and Age and Adverse CV Outcomes in Systemic Sclerosis
Patients with systemic sclerosis may be at a higher risk for developing heart failure and other cardiovascular complications, but age and gender might also play a role.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 27, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
FDA approves Roche ’s Actemra for the treatment of COVID-19 in hospitalised adults
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19Since the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra worldwideActemra is approved for this use in more than 30 countries for the treatment of COVID-19Basel, 21 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra ® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalised adult patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasi...
Source: Roche Media News - December 21, 2022 Category: Pharmaceuticals Source Type: news
Combo Therapy Shows Mixed Results for SSc-Related Lung Disease Combo Therapy Shows Mixed Results for SSc-Related Lung Disease
A study of mycophenolate mofetil alone and in combination with pirfenidone for scleroderma-related interstitial lung disease showed mixed results.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 17, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news
Safer Alternative to Cyclophosphamide at Hand for ILD?
(MedPage Today) -- PHILADELPHIA -- Rituximab (Rituxan) matched IV cyclophosphamide for improving lung function in patients with interstitial lung disease (ILD) related to systemic sclerosis and other connective tissue diseases, and was associated... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2022 Category: Rheumatology Source Type: news
Consumer Health: What do you know about scleroderma?
Scleroderma, also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin. It also may cause problems in the blood vessels, internal organs and digestive tract. About 75,000 –100,000 people in the U.S. have scleroderma, according to the American College of Rheumatology, and it occurs much more often in women than in men. Scleroderma often is categorized as "limited" or "diffuse," which refers only to the degree… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 9, 2022 Category: Databases & Libraries Source Type: news
Autoantibodies in Monitoring and Treatment of Scleroderma Autoantibodies in Monitoring and Treatment of Scleroderma
Learn more about the role antinuclear autoantibodies could have in the management and treatment of scleroderma.Current Opinion in Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Predictors of Progression to Systemic Sclerosis Predictors of Progression to Systemic Sclerosis
A better understanding of the characteristics associated with the progression of Raynaud ' s phenomenon to systemic sclerosis could lead to earlier diagnosis and treatment.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Drug Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 -- Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition.
The disease, a subset of scleroderma, hardens the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2022 Category: General Medicine Source Type: news
Tofacitinib Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 -- Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition.
The disease, a subset of scleroderma, hardens the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2022 Category: General Medicine Source Type: news
Bob Saget Scleroderma Fundraiser Tribute Show Raises $1.2 Million
Bob Saget's celeb friends picked up the baton and raised $1.2 million for scleroderma research, a cause near and dear to Bob's heart. #baton #celebfriends #bobsaget (Source: Reuters: Health)
Source: Reuters: Health - September 22, 2022 Category: Consumer Health News Source Type: news
Cell-killing cancer therapy shows promise for a devastating autoimmune disorder
Opening a new frontier in fighting autoimmune disease, researchers have successfully treated five lupus patients with a novel cell therapy that turns run-of-the-mill immune cells into specialized hunters of rogue cells helping fuel illness. The patients treated with the new therapy all saw their severe symptoms, including kidney and other organ dysfunction, largely disappear.
The results “are phenomenal,” says Betty Diamond, an immunologist and rheumatologist at the Feinstein Institutes for Medical Research who cares for lupus patients and was not involved in the work. Despite her excitement, she cautions that th...
Source: ScienceNOW - September 15, 2022 Category: Science Source Type: news
Bob Saget Scleroderma Fundraiser Turns Into Tribute Show, Celeb Pals Step In
Bob Saget's famous friends are stepping up to pick up the baton on Bob's fundraising for a rare disease. #bobsaget #baton #celebpalsstep (Source: Reuters: Health)
Source: Reuters: Health - August 3, 2022 Category: Consumer Health News Source Type: news
Durable Efficacy for Drug Preventing Lung Progression in Systemic Sclerosis
(MedPage Today) -- Patients with interstitial lung disease (ILD) related to systemic sclerosis continued to see less progression when treated with nintedanib (Ofev) in the pivotal 100-week SENSCIS trial, researchers said.
Among participants who... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - July 20, 2022 Category: Rheumatology Source Type: news
New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses
The Food and Drug Administration has approved a new diagnostic blood test to detect monospecific Ribosomal P antibodies to support a diagnosis of systemic lupus erythematosus.WebMD Health News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 17, 2022 Category: Pathology Tags: Rheumatology News Source Type: news
